Dr. Cho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1984 - 1988
Vanderbilt University School of MedicineClass of 1984
Certifications & Licensure
MI State Medical License 1998 - 2026- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Elected Member The American Society for Clinical Investigation, 2000
Publications & Presentations
PubMed
- 2 citationsProgestogen-driven B7-H4 contributes to onco-fetal immune tolerance.Jiali Yu, Yijian Yan, Shasha Li, Ying Xu, Abhijit Parolia
Cell. 2024-08-22 - 4 citationsCell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.Ian Beddows, Huihui Fan, Karolin Heinze, Benjamin K Johnson, Anna Leonova
Cancer Research. 2024-01-02 - 1 citationsA framework for assessing interactions for risk stratification models: the example of ovarian cancer.Minh Tung Phung, Alice W Lee, Karen McLean, Hoda Anton-Culver, Elisa V Bandera
Journal of the National Cancer Institute. 2023-11-08
Press Mentions
Genomics and Molecular Mechanisms of High Grade Serous Ovarian Cancer: The 12th Biennial Rivkin Center Ovarian Cancer Research SymposiumAugust 1st, 2019
Grant Support
- Molecular Pathogenesis Of Ovarian Endometrioid AdenocarcinomasNational Cancer Institute2007–2011
- Molecular Pathogenesis Of Ovarian Endometrioid AdenocarcNational Cancer Institute2002–2006
- Molecular Markers For Cervical Cancer ProgressionNational Cancer Institute2003
- Ovarian Tumor ProjectNational Cancer Institute1999–2002
- FHIT Gene Alterations In Cervical Cancer PathogenesisNational Cancer Institute1998–2000
- Molecular Pathogenesis Of Cervical CancerNational Cancer Institute1998–1999
- Molecular Pathogenesis Of Cervical CancerNational Cancer Institute1995–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
